Genki Global Dining Concepts Corporation (TYO:9828)

CTI BioPharma Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	10,241	11,952	10,547	7,688	6,995	5,261
Cash & Short-Term Investments	10,241	11,952	10,547	7,688	6,995	5,261
Cash Growth	12.70%	13.32%	37.19%	9.91%	32.96%	51.83%
Receivables	2,026	2,372	2,505	1,790	1,135	910
Inventory	748	774	666	863	525	505
Other Current Assets	788	736	557	722	653	688
Total Current Assets	13,803	15,834	14,275	11,063	9,308	7,364
Property, Plant & Equipment	11,754	11,796	11,436	12,230	10,207	9,666
Long-Term Investments	6,620	4,919	5,325	5,500	5,468	5,130
Other Intangible Assets	264	284	335	547	559	512
Long-Term Deferred Tax Assets	-	1,980	1,401	1,419	1,366	1,268
Other Long-Term Assets	1	1	2	1	2	2
Total Assets	32,442	34,814	32,774	30,760	26,910	23,942
Accounts Payable	2,392	2,652	2,367	2,696	1,876	1,607
Accrued Expenses	168	2,354	2,326	2,008	1,748	1,494
Current Portion of Long-Term Debt	1,117	1,231	1,231	1,228	1,035	1,498
Current Portion of Leases	-	1,062	1,251	1,356	1,063	1,009
Current Income Taxes Payable	290	1,496	1,049	288	358	53
Other Current Liabilities	4,598	2,018	2,433	2,275	1,663	1,588
Total Current Liabilities	8,565	10,813	10,657	9,851	7,743	7,249
Long-Term Debt	585	780	2,011	3,235	3,961	3,284
Long-Term Leases	4,932	5,127	5,623	6,557	5,095	4,572
Other Long-Term Liabilities	1,036	1,034	947	818	810	740
Total Liabilities	15,118	17,754	19,238	20,461	17,609	15,845
Common Stock	100	100	100	100	100	100
Additional Paid-In Capital	2,400	2,402	2,398	2,396	2,396	2,396
Retained Earnings	14,631	14,293	10,745	7,747	6,866	5,780
Treasury Stock	-77	-77	-77	-78	-77	-76
Comprehensive Income & Other	270	342	370	134	16	-103
Shareholders' Equity	17,324	17,060	13,536	10,299	9,301	8,097
Total Liabilities & Equity	32,442	34,814	32,774	30,760	26,910	23,942
Total Debt	6,634	8,200	10,116	12,376	11,154	10,363
Net Cash (Debt)	3,607	3,752	431	-4,688	-4,159	-5,102
Net Cash Growth	742.76%	770.53%	-	-	-	-
Net Cash Per Share	204.28	212.49	24.41	-265.55	-235.58	-289.00
Filing Date Shares Outstanding	17.66	17.66	17.66	17.65	17.66	17.66
Total Common Shares Outstanding	17.66	17.66	17.66	17.65	17.66	17.66
Working Capital	5,238	5,021	3,618	1,212	1,565	115
Book Value Per Share	981.11	966.12	766.61	583.36	526.80	458.61
Tangible Book Value	17,060	16,776	13,201	9,752	8,742	7,585
Tangible Book Value Per Share	966.16	950.04	747.64	552.37	495.14	429.61

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.